Online inquiry

IVTScrip™ mRNA-Human AES, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12577MR)

This product GTTS-WK12577MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AES protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001130.6
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 166
UniProt ID Q08117
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AES, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12577MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK14370MR IVTScrip™ mRNA-Human ADRBK2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADRBK2
GTTS-WK20942MR IVTScrip™ mRNA-Human ANKZF1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKZF1
GTTS-WK11911MR IVTScrip™ mRNA-Human ADAP2, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADAP2
GTTS-WK23303MR IVTScrip™ mRNA-Human ASCC2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASCC2
GTTS-WK18807MR IVTScrip™ mRNA-Human ANKRD20A12P, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD20A12P
GTTS-WK2421MR IVTScrip™ mRNA-Human Go-alpha, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Go-alpha
GTTS-WK8931MR IVTScrip™ mRNA-Human ADGB, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGB
GTTS-WK1218MR IVTScrip™ mRNA-Human SOST, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA SOST
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW